Next-generation flu vaccine delivers a stronger immune response to the A(H3N2) influenza strain in a new clinical trial, outperforming traditional egg- and cell-grown vaccines and highlighting the potential for improved seasonal protection.
https://bit.ly/4uTCExz
Explore our work in research, public health and education at the Doherty Institute.
